Skip to Main Content

Paper Details

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
Life Sci
4
2023
AD, Alzheimer's disease, CMA, NDDs, Neurodegenerative diseases, PD, Parkinson's disease, apomorphine, combined metabolic activators, degeneration, glutathione, human, hyperemia, metabolic abnormalities, mitochondrial dysfunction, neurodegenerative diseases, neurons, nicotinamide adenine dinucleotide, patients, rats
Author NameAffiliation
Muhammad ArifKTH Royal Institute of Technology
Cheng ZhangKTH Royal Institute of Technology, Sweden School of Pharmaceutical Sciences, Zhengzhou University
Jens NielsenChalmers University of Technology
Jens NielsenChalmers University of Technology
Mathias Uhl??nKTH Royal Institute of Technology
Mathias Uhl??nKTH Royal Institute of Technology
Adil MardinogluKTH Royal Institute of Technology, King's College London
Adil MardinogluKTH Royal Institute of Technology, King's College London
  • 1 - 8

Datasets

Release 1.2